• The need for rapid and accurate antiepileptic drug measurement in blood is well established. A substrate-labeled fluorescent immunoassay (FIA) has been developed that can measure phenobarbital, phenytoin, primidone, and carbamazepine in serum. To our knowledge, the primidone and carbamazepine assays have not previously been tested in a field trial. We compared FIA and the wellestablished antiepileptic drug immunoassay technique EMIT for the quantitation of both carbamazepine and primidone. In our hands, the FIA method compared favorably with the EMIT method for accuracy and reliability but is somewhat more time consuming. This method has the advantage of being more sensitive, however, and requires only a finger-stick blood sample. Because of this and the simplicity of the equipment required, the FIA system should also be relatively inexpensive to set up and to operate.
Smith DB, Carl GF. Fluorescent Immunoassay for Determining Antiepileptic Drug Concentrations: Clinical Usefulness. Arch Neurol. 1982;39(6):363–366. doi:10.1001/archneur.1982.00510180041010
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.